This announcement is a separate document:
基石藥業-B：(I)建議根據首次公開發售後僱員持股計劃註銷及向現有承授人重授購股權；及(II)建議修訂股份激勵計劃
CSTONE PHARMA-B: (I) PROPOSED CANCELLATION AND RE-GRANTS OF OPTIONS TO EXISTING GRANTEES UNDER THE POST-IPO ESOP; AND (II) PROPOSED AMENDMENTS TO THE SHARE INCENTIVE SCHEMES
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.